Published in Br J Cancer on June 20, 2006
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. Crit Rev Oncol Hematol (2010) 1.82
Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables. Ther Adv Med Oncol (2011) 1.32
Impact of smoking status on the biological behavior of lung cancer. Surg Today (2007) 1.14
Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Dis (2013) 0.92
Cyclooxygenase-2 inhibition and hypoxia-induced pulmonary hypertension: effects on pulmonary vascular remodeling and contractility. Trends Cardiovasc Med (2009) 0.92
Prognostic significance of COX-2 immunohistochemical expression in colorectal cancer: a meta-analysis of the literature. PLoS One (2013) 0.90
COX-2/EGFR expression and survival among women with adenocarcinoma of the lung. Carcinogenesis (2008) 0.89
Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells. BMC Cancer (2008) 0.86
Overview of the molecular carcinogenesis of mouse lung tumor models of human lung cancer. Toxicol Pathol (2007) 0.82
Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy. World J Surg Oncol (2015) 0.79
Prognostic significance of cyclooxygenase-2 expression in patients with hepatocellular carcinoma: a meta-analysis. Arch Med Sci (2016) 0.79
Expression of STAT5, COX-2 and PIAS3 in correlation with NSCLC histhopathological features. PLoS One (2014) 0.78
Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis. PLoS One (2011) 0.76
Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer. PLoS One (2016) 0.76
Prognostic factors in resected lung carcinomas. EJC Suppl (2013) 0.75
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med (1998) 19.07
Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis (1985) 19.03
Cancer incidence and mortality in Europe, 2004. Ann Oncol (2005) 6.47
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A (1997) 4.84
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res (2000) 4.18
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer (2005) 3.40
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res (1998) 3.20
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J (2001) 3.04
Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res (1998) 2.92
Sulindac for polyposis of the colon. J Surg Oncol (1983) 2.34
Why there are two cyclooxygenase isozymes. J Clin Invest (2001) 2.13
Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res (1998) 2.11
NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res (1998) 2.00
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res (2001) 1.93
Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin Cancer Res (2000) 1.81
Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. Br J Cancer (2004) 1.79
Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res (2000) 1.64
Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR. J Biol Chem (2003) 1.60
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis. Eur Respir J (2002) 1.57
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer (2003) 1.54
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer (2002) 1.52
Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin Cancer Res (1999) 1.47
Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer (2000) 1.44
Role of cyclooxygenase-2 in colorectal cancer. Cancer Metastasis Rev (2004) 1.41
Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Cancer (2001) 1.39
Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head Neck (2002) 1.32
Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol (2002) 1.27
Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers. J Clin Oncol (2004) 1.25
The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature. Br J Cancer (2003) 1.14
Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer. Clin Cancer Res (2005) 1.13
HER2 and COX2 expression in human prostate cancer. Eur J Cancer (2004) 1.09
[VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis]. Rev Mal Respir (2002) 1.05
Elevated cyclooxygenase-2 expression correlates with distant metastases in breast cancer. Anticancer Res (2004) 1.05
Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients. Int J Cancer (2005) 1.04
Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues and non-small cell lung cancers. Jpn J Cancer Res (1999) 1.04
Cyclooxygenase-2 is expressed frequently and early in Barrett's oesophagus and associated adenocarcinoma. Histopathology (2003) 1.03
Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer. Ann Surg (2002) 1.01
Molecular and biological factors in the prognosis of non-small cell lung cancer. Eur Respir J (1995) 0.99
Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer. Lung Cancer (2003) 0.97
Prognostic significance of cyclooxygenase 2 expression in 259 cases of non-small cell lung cancer. Arch Pathol Lab Med (2005) 0.91
Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma. Cancer (2002) 0.90
Prognostic markers in resectable non-small cell lung cancer. Hematol Oncol Clin North Am (1997) 0.87
HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer. Acta Oncol (2004) 0.87
COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung. A study of 117 patients from Brazil. Am J Clin Pathol (2004) 0.86
Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancer. Lung Cancer (2005) 0.84
Co-expression of Cox-2 and EGFR in stage I human bronchial adenocarcinomas. Lung Cancer (2004) 0.80
COX-2 expression during early lung squamous cell carcinoma oncogenesis. Eur Respir J (2005) 0.80
Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas. Ann Thorac Surg (2004) 0.77
Competence-specific induction of recA is required for full recombination proficiency during transformation in Streptococcus pneumoniae. Mol Microbiol (1998) 5.01
Stacks on tracks: the plant Golgi apparatus traffics on an actin/ER network. Plant J (1998) 4.87
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer (2007) 4.44
Give them prizes, and they will come: contingency management for treatment of alcohol dependence. J Consult Clin Psychol (2000) 4.19
A community training scheme in cardiopulmonary resuscitation. Br Med J (Clin Res Ed) (1984) 3.83
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol (2000) 3.69
[Presentation of the French translation of the Breast Imaging Reporting System and Data System (BI-RADS)]. Gynecol Obstet Fertil (2005) 3.68
Construction and evaluation of new drug-resistance cassettes for gene disruption mutagenesis in Streptococcus pneumoniae, using an ami test platform. Gene (1995) 3.63
Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol (1990) 3.54
Role of auxilin in uncoating clathrin-coated vesicles. Nature (1995) 3.42
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer (2005) 3.40
Anaesthesia for chronic spinal cord lesions. Anaesthesia (1998) 3.17
Psychosocial correlates of oestrogen and progesterone receptors in breast cancer. Lancet (1990) 3.14
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J (2009) 3.08
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J (2001) 3.04
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites. Ann Oncol (2002) 3.03
NICE guidelines for central venous catheterization in children. Is the evidence base sufficient? Br J Anaesth (2004) 2.94
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
Development of competence in Streptococcus pneumonaie: pheromone autoinduction and control of quorum sensing by the oligopeptide permease. Mol Microbiol (1998) 2.42
Maintenance chemotherapy for small cell lung cancer: a critical review of the literature. Lung Cancer (1998) 2.27
Antimicrobial activity of synthetic magainin peptides and several analogues. Proc Natl Acad Sci U S A (1988) 2.24
Human melanoma progression in skin reconstructs : biological significance of bFGF. Am J Pathol (2000) 2.23
Adaptation to the environment: Streptococcus pneumoniae, a paradigm for recombination-mediated genetic plasticity? Mol Microbiol (2000) 2.22
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J (2009) 2.21
Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient. Gut (2000) 2.16
Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients. Clin Infect Dis (2001) 2.03
Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis. Ann Oncol (2006) 1.92
Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature. Lung Cancer (2005) 1.92
The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature. Br J Cancer (2001) 1.82
Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. Br J Cancer (2004) 1.79
Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages. EMBO J (1991) 1.79
Regulation of retinal and optic nerve blood flow. Arch Ophthalmol (1998) 1.76
Reinforcing compliance with non-drug-related activities. J Subst Abuse Treat (2001) 1.75
Comparison of Photosynthetic Performance in Triazine-Resistant and Susceptible Biotypes of Amaranthus hybridus. Plant Physiol (1983) 1.71
Bias in awarding research grants. Br Med J (Clin Res Ed) (1986) 1.71
Scoring systems in cancer patients admitted for an acute complication in a medical intensive care unit. Crit Care Med (2000) 1.69
Nucleotide sequence of the Streptococcus pneumoniae hexB mismatch repair gene: homology of HexB to MutL of Salmonella typhimurium and to PMS1 of Saccharomyces cerevisiae. J Bacteriol (1989) 1.67
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond) (2010) 1.61
Head injury outcome prediction in the emergency department: a role for protein S-100B? J Neurol Neurosurg Psychiatry (2002) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis. Eur Respir J (2002) 1.57
Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents (2007) 1.57
Molecular cloning of cDNA coding for kidney aldose reductase. Regulation of specific mRNA accumulation by NaCl-mediated osmotic stress. J Biol Chem (1989) 1.56
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer (2003) 1.54
Lobeline: structure-affinity investigation of nicotinic acetylcholinergic receptor binding. J Med Chem (1999) 1.53
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer (2002) 1.52
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients. Br J Cancer (2004) 1.52
Diminished interleukin-8 (IL-8) production in the fetal wound healing response. J Surg Res (1998) 1.48
Heidelberg retinal flowmetry: factors affecting blood flow measurement. Br J Ophthalmol (1998) 1.47
Impact of aortic grafts on arterial pressure: a computational fluid dynamics study. Eur J Vasc Endovasc Surg (2011) 1.46
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer (2001) 1.44
Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease. Proc Natl Acad Sci U S A (1985) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis (2000) 1.41
Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis. Lung Cancer (2002) 1.40
[EGF-R expression correlation between biopsy and surgical specimens of lung carcinoma]. Rev Mal Respir (2003) 1.39